Table 4.
Study variables | Norway (n = 124) | Canada (n = 155) |
---|---|---|
% | % | |
Age | ||
<30 years | 12 | 22 |
30–39 years | 32 | 39 |
40–49 years | 28 | 23 |
50+ years | 25 | 17 |
Prefer not to say | 2 | – |
Gender | ||
Male | 19 | 15 |
Female | 79 | 83 |
Prefer not to say | 2 | 3 |
Hours | ||
Full‐time | 82 | 80 |
Part‐time | 18 | 20 |
Years of working experience | ||
0–5 | 15 | 27 |
6–10 | 22 | 19 |
11–15 | 16 | 18 |
16–20 | 20 | 12 |
21–25 | 13 | 15 |
25+ | 14 | 9 |
Education* | ||
Diploma | – | 10 |
Bachelor’s degree | 95 | 77 |
Master’s degree or higher | 5 | 12 |
Prefer not to say | – | 1 |
Position* | ||
Pre‐treatment and dosimetry | 41 | 13 |
Treatment therapist | 39 | 68 |
Educator | 11 | 5 |
Other | 9 | 15 |
Presence of work‐related stressors due to COVID‐19 | ||
Changes in staffing due to COVID‐19 | 40 | 41 |
Changes in patient volumes due to COVID‐19 | 13 | 21 |
Changes in PPE usage due to COVID‐19 | 29 | 59* |
Changes in household income due to COVID‐19 | – a | 20 |
Fear of transmitting COVID‐19 into workplace | 68 | 52* |
Fear of transmitting COVID‐19 from work to family/friends | 57 | 76* |
Acquiring COVID‐19 from work | 34 | 59* |
Psychological impact due to COVID‐19 (scale 1–5) | Mean (SD) | Mean (SD) |
---|---|---|
Work‐related stress due to COVID‐19 | 3.0 (1.3) | 4.2 (0.8)* |
Work‐related anxiety due to COVID‐19 | 2.2 (1.1) | 3.9 (1.1)* |
Work‐related insomnia due to COVID‐19 | 1.9 (1.0) | 2.8 (1.3)* |
Work‐related depression due to COVID‐19 | 2.0 (1.0) | 2.8 (1.2)* |
Chi‐square significant differences for categorical variables and independent sample t‐test for significant mean differences between Canadian and Norwegian respondents, *P < 0.05.
Value is suppressed due to small cell count.